Concepedia

Rates, management and outcome of bleeding complications during edoxaban therapy in daily care – results from the DRESDEN NOAC REGISTRY

Jan Beyer‐Westendorf, Sandra Marten, Christiane Naue, Luise Tittl, Ulrike Hänsel, Ines Beyer-Westendorf, Heike Mizera, Thomas Schreier, E. G. Festerling, Antje Reitter,

Thrombosis Research · 2020 · 10 citations · 40 references

DOI

Concepts

References

40

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha et al. · EP Europace · 2016 · 6.5K citations · Full text

, , +16

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha et al. · European Heart Journal · 2016 · 6.4K citations · Full text

, , +16

Antithrombotic Therapy for VTE Disease

Clive Kearon, Elie A. Akl, Anthony J. Comerota et al. · CHEST Journal · 2012 · 6.1K citations · Full text

, , +12

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 5.1K citations · Full text

, , +17